Literature DB >> 28067869

Clinical and biological markers of premature aging after autologous SCT in childhood cancer.

A Vatanen1, M Hou2, T Huang2, O Söder2, T Jahnukainen3, M Kurimo1, T H Ojala4, T Sarkola4, M Turanlahti4, U M Saarinen-Pihkala1, K Jahnukainen1,2.   

Abstract

The aim of this study was to analyze the prevalence of frailty and physical health limitations among long-term survivors of high-risk neuroblastoma (HR NBL) and to investigate whether frail health is associated with variables of cardiovascular function, markers of inflammation and telomere length. A national study cohort of 19 (median age 22, range 16-30 years) long-term (>10 years) HR NBL survivors was studied and the findings were compared with 20 age- and sex-matched controls. Frailty was defined as ⩾3 of the following conditions: low muscle mass, low energy expenditure, slow running and weakness. The prevalence of frailty was significantly higher among the HR NBL survivors 9/19 (47%) than among the controls (0%). Thirteen (68%) of the survivors reported significant physical health limitations in vigorous activities, as opposed to none of the controls. The HR NBL survivors had significantly shorter telomere length and higher serum levels of high sensitivity C-reactive protein than did the controls. Frail health and poor physical functioning are prevalent among HR NBL survivors and suggest premature aging. Survivors with gonadal damage, very low fat mass percentage, low glycosylated hemoglobin A1c and increased common carotid artery intima-media thickness may be more prone to early aging after high dose therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067869     DOI: 10.1038/bmt.2016.334

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  31 in total

1.  Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT.

Authors:  A Vatanen; T H Ojala; T Sarkola; M Turanlahti; T Jahnukainen; U M Saarinen-Pihkala; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

Review 2.  Hallmarks of telomeres in ageing research.

Authors:  J W Shay; W E Wright
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Radiotherapy-related arterial intima thickening and plaque formation in childhood cancer survivors detected with very-high resolution ultrasound during young adulthood.

Authors:  Anu Vatanen; Taisto Sarkola; Tiina H Ojala; Maila Turanlahti; Timo Jahnukainen; Ulla M Saarinen-Pihkala; Kirsi Jahnukainen
Journal:  Pediatr Blood Cancer       Date:  2015-06-05       Impact factor: 3.167

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.

Authors:  Ulla M Saarinen-Pihkala; Liisa Hovi; Antti Koivusalo; Kirsi Jahnukainen; Riitta Karikoski; Hannu Sariola; Sakari Wikström
Journal:  Pediatr Blood Cancer       Date:  2012-04-10       Impact factor: 3.167

6.  Elevated serum C-reactive protein levels and early arterial changes in healthy children.

Authors:  Mikko J Järvisalo; Aimo Harmoinen; Maarit Hakanen; Ulla Paakkunainen; Jorma Viikari; Jaakko Hartiala; Terho Lehtimäki; Olli Simell; Olli T Raitakari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

7.  Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

Authors:  Vanessa B Sheppard; Leigh Anne Faul; George Luta; Jonathan D Clapp; Rachel L Yung; Judy Huei-Yu Wang; Gretchen Kimmick; Claudine Isaacs; Michelle Tallarico; William T Barry; Brandelyn N Pitcher; Clifford Hudis; Eric P Winer; Harvey J Cohen; Hyman B Muss; Arti Hurria; Jeanne S Mandelblatt
Journal:  J Clin Oncol       Date:  2014-06-16       Impact factor: 44.544

Review 8.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

9.  Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study.

Authors:  Kirsten K Ness; Kevin R Krull; Kendra E Jones; Daniel A Mulrooney; Gregory T Armstrong; Daniel M Green; Wassim Chemaitilly; Webb A Smith; Carmen L Wilson; Charles A Sklar; Kyla Shelton; Deo Kumar Srivastava; Sabeen Ali; Leslie L Robison; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

10.  Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Yutaka Yasui; Yan Liu; Marilyn Stovall; Ray Hutchinson; Jill Ginsberg; Charles Sklar; Leslie L Robison
Journal:  Cancer       Date:  2002-12-01       Impact factor: 6.921

View more
  12 in total

Review 1.  Frailty and aging in cancer survivors.

Authors:  Kirsten K Ness; Matthew D Wogksch
Journal:  Transl Res       Date:  2020-05-01       Impact factor: 7.012

Review 2.  Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer.

Authors:  Kirsten K Ness; James L Kirkland; Maria Monica Gramatges; Zhaoming Wang; Mondira Kundu; Kelly McCastlain; Xiujie Li-Harms; Jinghui Zhang; Tamar Tchkonia; Saskia Martine Francesca Pluijm; Gregory T Armstrong
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

3.  Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.

Authors:  Priyanka Banerjee; Elizabeth A Olmsted-Davis; Anita Deswal; Minh Th Nguyen; Efstratios Koutroumpakis; Nicholas L Palaskas; Steven H Lin; Sivareddy Kotla; Cielito Reyes-Gibby; Sai-Ching J Yeung; Syed Wamique Yusuf; Momoko Yoshimoto; Michihiro Kobayashi; Bing Yu; Keri Schadler; Joerg Herrmann; John P Cooke; Abhishek Jain; Eduardo Chini; Nhat-Tu Le; Jun-Ichi Abe
Journal:  J Cardiovasc Aging       Date:  2022-04-29

4.  Diagnosis of Idiopathic Premature Ovarian Failure by Color Doppler Ultrasound under the Intelligent Segmentation Algorithm.

Authors:  Lanlan Yu; Xiaofeng Qing
Journal:  Comput Math Methods Med       Date:  2022-05-25       Impact factor: 2.809

Review 5.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

Review 6.  Aging in Adult Survivors of Childhood Cancer: Implications for Future Care.

Authors:  Ilse Schuitema; Tyler Alexander; Melissa M Hudson; Kevin R Krull; Kim Edelstein
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

7.  Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study.

Authors:  Emma Jacobine Verwaaijen; Annelienke van Hulst; Marta Fiocco; Annelies Hartman; Martha Grootenhuis; Saskia Pluijm; Rob Pieters; Erica van den Akker; Marry M van den Heuvel-Eibrink
Journal:  JMIR Res Protoc       Date:  2022-04-11

Review 8.  Measuring frailty in younger populations: a rapid review of evidence.

Authors:  Gemma F Spiers; Tafadzwa Patience Kunonga; Alex Hall; Fiona Beyer; Elisabeth Boulton; Stuart Parker; Peter Bower; Dawn Craig; Chris Todd; Barbara Hanratty
Journal:  BMJ Open       Date:  2021-03-22       Impact factor: 2.692

Review 9.  Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.

Authors:  Annika Ritz; Eberhard Lurz; Michael Berger
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

10.  Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.

Authors:  Frank Berthold; Angela Ernst; Barbara Hero; Thomas Klingebiel; Bernhard Kremens; Freimut H Schilling; Thorsten Simon
Journal:  Br J Cancer       Date:  2018-07-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.